BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Apr 18, 2011
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Human Genome Sciences, GlaxoSmithKline sales and marketing update

In a presentation, Human Genome Sciences said it and partner GlaxoSmithKline launched Benlysta belimumab in the U.S. to treat patients with active, autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy. The biotech also launched a patient assistance program for Benlysta under which uninsured patients who earn less than five times the...

Read the full 254 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >